Jump to Navigation
Trends and Sentiments
Comments and Analysis
The 10 things in advertising you need to know today
Cazeneuve appointed as France’s prime minister
South Korea's Park would leave economy mired in...
Canada’s food guide should be modernized with consumers...
Canada’s trade alternatives post-Trump and Brexit
Exchange traded funds: taking over the markets
The Most And Least Loved Stocks In The S&P 500
Vale's Successful Cost Reduction And Capital...
Franklin Street Properties: Poor Fundamentals And Massive...
Shares in spreadbetting firms dive on FCA crackdown
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
3 Biotech Stocks With A History Of Positive Earnings Surprises
11 Large-Cap, Low Debt Stocks For Defensive Investors
9 Biotechs Gaining Analyst Attention
2 Biotech Stocks Leading This Rally
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech
Top Q4 Buys And Sells Of Healthcare-Focused Hambrecht And Quist Capital Management
Trading Biotech In Pairs: A Better Way To Hedge
Alexion Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Hedging 5 Stocks That Were Upgraded Friday
Analyzing 19 High Valuation Put Candidates
Top Mid- And Large-Cap Biotech Picks By Legendary Fund Managers
Alexion Pharmaceuticals: A Tricky Mix Of Biotech And Pharma
4 Heavily Traded Biotechs With The Highest P/B Ratios And PSRs Over 10
4 Healthcare Stocks To Acquire Now
Recent Performance Review For 7 Biotech Equities
Analyzing Friday's Noteworthy Insider Buys And Sells In The Healthcare Sector
Analyzing Friday's Noteworthy Insider Trades In Healthcare And Tech Sectors
How Much Further Can Rare Diseases Carry BioMarin?
Biotech Bull Market Intact: Rayno Biopharmaceutical Portfolio Outperforms
Consider CME Group: It Is A Different Kind Of Financial Company
The 'Best CEO' Jinx Could Hit AutoZone
Questcor: A Strong Play In Pharma
Large-Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
'Footloose' Comes To Brussels - Europe...
Gateley on the acquisition trail as firm enjoys...
EUR/GBP: 1.1837 USD/EUR: 1.0772 JPY/USD: 114.1090
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions